NIH Offers New Cell Therapy to Fight HPV Warts
Published Date: 7/16/2026
Notice
Summary
The National Cancer Institute has created a new way to make special immune cells called PILs that can fight chronic HPV infections causing painful growths in the throat and genital areas. This new cell therapy could reduce the need for repeated surgeries, improving patients’ lives and cutting healthcare costs. Researchers are now looking for partners to help develop and license this promising treatment soon.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Potential New Therapy for Chronic HPV 6/11
Researchers at the National Cancer Institute developed papilloma-infiltrating lymphocytes (PILs) to treat chronic human papillomavirus (HPV) type 6 or 11 infections that cause recurrent respiratory papillomatosis (RRP) and anogenital condyloma. This approach could reduce the need for repeated surgical debulking or laser ablation, improve quality of life, and cut ongoing healthcare costs for patients with chronic HPV 6/11 infections.
License and Co-Development Opportunity for Biotech
The National Cancer Institute is seeking industry partners to license and co-develop PIL cell therapy for HPV 6/11 conditions; the technology is at pre-clinical (in vivo validation) stage and carries NIH Reference Number E-143-2024-0. A PCT patent application was filed on October 20, 2025 (PCT/US2025/051640), and interested biotech firms focused on T cell therapies are invited to pursue licensing or collaboration.
RRP Drug Development May Qualify for Incentives
The notice states drug development for recurrent respiratory papillomatosis (RRP) may qualify for regulatory incentives due to the rarity of the disease. Sponsors developing PIL-based therapies for RRP could be eligible for such incentives during clinical development and regulatory review.
Method Could Enable Broader Non‑Cancer Treatments
The NCI reports the PIL manufacturing method can isolate and expand antigen-specific lymphocytes from non-cancerous papilloma tissue, potentially enabling adoptive cell therapies for a broader range of non-malignant diseases and supporting generation of T cell receptor (TCR) libraries for research and therapeutic use.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
Previous / Next Documents
Previous: 2026-14346, Government Owned Invention Available for License: Selective Expansion of Engineered TCR-T Cells for Use in Adoptive Cell Immunotherapy
The National Cancer Institute has invented a cool new way to grow special immune cells called TCR-T cells that can better fight cancer. This method helps companies make more powerful, targeted cell therapies by boosting the right cells and cutting out the extras. If you’re in biotech or cancer treatment, this is your chance to license a game-changing tool that could speed up cancer cures and bring new treatments to patients faster.
Next: 2026-14349, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Grazing Management: Range Improvement Agreements and Permits Materials
The Bureau of Land Management wants to keep collecting info about grazing permits and improvements on public lands, making sure the paperwork stays clear and easy. Ranchers and land users are affected, but no big changes or costs are expected. You’ve got until August 17, 2026, to share your thoughts and help keep things smooth and simple!